Research indicates that GenderGP has provided hormone therapy and puberty blockers to thousands of transgender people worldwide. Evidence from the service shows it has reached people from numerous countries, reflecting the significant global demand for specialist transgender healthcare that traditional medical systems often struggle to meet.
The scale of people supported highlights what studies consistently demonstrate: there is substantial unmet need for transgender healthcare internationally. Guidelines from major medical organisations emphasise that access to appropriate specialist care remains limited in many healthcare systems, creating barriers for trans individuals seeking medically necessary treatment.
When specialist services like GenderGP emerge to fill these gaps, the volume of people seeking support often exceeds initial expectations. This pattern reflects broader research findings about transgender healthcare access, which show that when barriers are reduced and specialist knowledge is available, demand reveals the true extent of need that was previously hidden or unaddressed.
The international reach of such services demonstrates how geographical location can significantly impact healthcare access for transgender people. Evidence shows that many individuals must look beyond their local healthcare systems to find practitioners with appropriate expertise and understanding of transgender medical needs, highlighting ongoing challenges in healthcare provision for this population.